40 related articles for article (PubMed ID: 9542319)
1. Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy.
Schwind S; Jentzsch M; Bach E; Stasik S; Thiede C; Platzbecker U
Curr Treat Options Oncol; 2020 Jan; 21(1):8. PubMed ID: 32002673
[TBL] [Abstract][Full Text] [Related]
2. Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid Leukemia.
Jentzsch M; Schwind S; Bach E; Stasik S; Thiede C; Platzbecker U
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31652787
[TBL] [Abstract][Full Text] [Related]
3. Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations.
Jutzi JS; Basu T; Pellmann M; Kaiser S; Steinemann D; Sanders MA; Hinai ASA; Zeilemaker A; Bojtine Kovacs S; Koellerer C; Ostendorp J; Aumann K; Wang W; Raffoux E; Cassinat B; Bullinger L; Schlegelberger B; Valk PJM; Pahl HL
Blood; 2019 Apr; 133(16):1766-1777. PubMed ID: 30755419
[TBL] [Abstract][Full Text] [Related]
4. FISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q).
Makishima H; Rataul M; Gondek LP; Huh J; Cook JR; Theil KS; Sekeres MA; Kuczkowski E; O'Keefe C; Maciejewski JP
Leuk Res; 2010 Apr; 34(4):447-53. PubMed ID: 19758696
[TBL] [Abstract][Full Text] [Related]
5. Automated detection of residual cells after sex-mismatched stem-cell transplantation - evidence for presence of disease-marker negative residual cells.
Erlecke J; Hartmann I; Hoffmann M; Kroll T; Starke H; Heller A; Gloria A; Sayer HG; Johannes T; Claussen U; Liehr T; Loncarevic IF
Mol Cytogenet; 2009 May; 2():12. PubMed ID: 19480690
[TBL] [Abstract][Full Text] [Related]
6. FISH monitoring of 100 courses of human leukemias: the cytogenetic viewpoint.
Gebhart E; Rösler W; Gramatzki M; Trautmann U
Int J Oncol; 2001 Sep; 19(3):617-23. PubMed ID: 11494045
[TBL] [Abstract][Full Text] [Related]
7. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
Wang HP; Li GX; Qiao ZH; Wang HW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
[TBL] [Abstract][Full Text] [Related]
8. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
9. [Detection of trisomy 8 with interphase fluorescence in situ hybridization in myelodysplastic syndromes].
Li J; Pan J; Xue Y; Wu C; Xie X; Guo Y; Ruan C
Zhonghua Xue Ye Xue Za Zhi; 2000 Apr; 21(4):179-81. PubMed ID: 11876976
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation.
Cuneo A; Bigoni R; Negrini M; Bullrich F; Veronese ML; Roberti MG; Bardi A; Rigolin GM; Cavazzini P; Croce CM; Castoldi G
Cancer Res; 1997 Mar; 57(6):1144-50. PubMed ID: 9067285
[TBL] [Abstract][Full Text] [Related]
11. Trisomy 12 in B-cell chronic lymphocytic leukemia: interphase study by in situ hybridization in 75 patients.
Coignet L; Berthéas MF; Vasselon C; Jaubert J; Reynaud J; Calmard-Oriol P; Brizard CP; Guyotat D
Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):129-34. PubMed ID: 8332448
[TBL] [Abstract][Full Text] [Related]
12. Detection and monitoring of trisomy 8 by fluorescence in situ hybridization in acute myeloid leukemia: a multicentric study.
Cuneo A; Bigoni R; Roberti MG; Bardi A; Rigolin GM; Piva N; Mancini M; Nanni M; Alimena G; Mecucci C; Matteucci C; La Starza R; Bernasconi P; Cavigliano P; Genini E; Zaccaria A; Testoni N; Carboni C; Castoldi G
Haematologica; 1998 Jan; 83(1):21-6. PubMed ID: 9542319
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and monitoring of chromosome aberrations in hematological malignancies by fluorescence in situ hybridization.
Döhner H; Stilgenbauer S; Fischer K; Schröder M; Bentz M; Lichter P
Stem Cells; 1995 Dec; 13 Suppl 3():76-82. PubMed ID: 8747992
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
